FDA.reportPublic FDA data

Application 065148

Type
ANDA
Sponsor
LANNETT CO INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NYSTATINNYSTATINSUSPENSION;ORAL100,000 UNITS/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0527-5121Nystatin Oral SuspensionNystatin Oral SuspensionLannett Company, Inc.ANDACurrent
0527-5121Nystatin Oral SuspensionNystatin Oral SuspensionLannett Company, Inc.ANDACurrent
0527-5121Nystatin Oral SuspensionNystatin Oral SuspensionLannett Company, Inc.ANDACurrent
0603-1481NystatinNystatinPar PharmaceuticalANDACurrent
21695-643NystatinNystatinRebel Distributors CorpANDACurrent
50090-0217NystatinNystatinA-S Medication SolutionsANDACurrent
68071-2644Nystatin Oral SuspensionNystatin Oral SuspensionNuCare Pharmaceuticals,Inc.ANDACurrent
68788-7956Nystatin Oral SuspensionNystatin Oral SuspensionPreferred Pharmaceuticals Inc.ANDACurrent
68788-7956Nystatin Oral SuspensionNystatin Oral SuspensionPreferred Pharmaceuticals Inc.ANDACurrent
68788-9072NystatinNystatinPreferred Pharmaceuticals, IncANDACurrent
80432-003NystatinNystatin Oral SuspensionTriRx Huntsville Pharmaceutical Services, LLCANDACurrent
80432-003nystatinNystatin Oral SuspensionTriRx Huntsville Pharmaceutical Services, LLCANDACurrent
80432-003NystatinNystatin Oral SuspensionTriRx Huntsville Pharmaceutical Services, LLCANDACurrent
80432-003nystatinNystatin Oral SuspensionTriRx Huntsville Pharmaceutical Services, LLCANDACurrent